Your browser doesn't support javascript.
loading
Changes in brain activity with tominersen in early-manifest Huntington's disease.
Hawellek, D J; Garces, P; Meghdadi, A H; Waninger, S; Smith, A; Manchester, M; Schobel, S A; Hipp, J F.
Affiliation
  • Hawellek DJ; Roche, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland.
  • Garces P; Roche, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland.
  • Meghdadi AH; Advanced Brain Monitoring Inc., Carlsbad, CA 92008, USA.
  • Waninger S; Advanced Brain Monitoring Inc., Carlsbad, CA 92008, USA.
  • Smith A; Ionis Pharmaceuticals Inc., Carlsbad, CA 92010, USA.
  • Manchester M; Roche, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland.
  • Schobel SA; F. Hoffmann-La Roche Ltd, Basel 4070, Switzerland.
  • Hipp JF; Roche, Pharmaceutical Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel 4070, Switzerland.
Brain Commun ; 4(3): fcac149, 2022.
Article in En | MEDLINE | ID: mdl-35774187
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Brain Commun Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Brain Commun Year: 2022 Document type: Article Affiliation country: Country of publication: